Therefore, although many patients lacked a second ANA test, most of these patients would not have met the criteria for inclusion in the early-onset ANA-positive JIA group, and their absence is unlikely to have significantly impacted the study. The gene discussed is BTG3; the disease is juvenile idiopathic arthritis.